Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc. is a biotechnology company that develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. It offers metabolome analysis services, including global profiling, targeted assays, flux analysis, and lipidomics, and develops biomarkers such as Phosphorylethanolamine for major depressive disorder, measured in blood plasma. The company provides solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It collaborates with the Institute for Advanced Biosciences and Keio University on metabolome analysis technology, was incorporated in 2003, and is based in Tsuruoka, Japan.